Adam Yang
Worked with various E. coli strains and cultured coliphage T4 to target those strains in an independent research project. Wrote a general review article about phage therapy. Currently studying the potential of using phage to address secondary bacterial infection in COVID-19 patients under some professors help.
Tags
- CreatiPhage – The Pioneer in China Adam Yang, an intern at Shanghai Institute of Phage, interviewed the co-founder of CreatiPhage, Nannan Wu. CreatiPhage is the first company applying phage therapy to humans in China, and seeks to promote the overall development of phage…
- The secret killer behind COVID-19 and the potential remedy This week, Adam Yang of Lake Forest Academy explores secondary bacterial infections behind COVID-19 deaths, and discusses how phage therapy may be used as a solution.
